Global Influenza Vaccines Market Is Anticipated To Witness Significant Growth Due To Rising Government Initiatives For Supporting Influenza Vaccination And Growing Prevalence Of Influenza

Influenza Vaccines Market
Influenza Vaccines Market

Overview:

Influenza vaccines protect people from getting sick with the flu. They also help reduce the spread of the flu and helps the community in staying healthy. Every year, flu vaccines prevent millions of illnesses and hospitalizations in the United States. They also lower the risk of serious flu complications in people who have certain health conditions.

To produce a flu vaccine, candidate vaccine viruses (CVVs) are selected by the World Health Organization and distributed to manufacturers. These CVVs are inoculated into cultured mammalian cells (instead of eggs). Then, the virus-containing fluid is collected and purified to make a recombinant influenza virus antigen. The recombinant virus is introduced into host cells that are Food and Drug Administration (FDA) qualified to grow the antigen. The recombinant virus delivers genetic instructions to the host cells to rapidly make the flu HA antigen.

Market Dynamics:

Growing business expansion by key players are estimated to augment growth of the global Influenza Vaccines Market during the forecast period. For instance, Seqirus announced that they are building a new biotech manufacturing plant in Australia in November 2020, for providing influenza vaccinations in the country and rest of the world. Moreover, high cost and increasing restriction in vaccine production are anticipated to restrain growth of the global influenza vaccines for market during the forecast period.

Impact of COVID-19:

The first case of COVID-19 infection was recognized in 2019 in China. In 2020, it was declared as a public health emergency by the World Health Organization. COVID-19 is caused by a virus and it mostly affects the lungs and causes difficulty in breathing. The pandemic had significant impact on several sectors globally.

Strict regulations were imposed in many regions for preventing the spread of the virus. These restrictions had a huge impact on many businesses around the world. The pandemic also affected the healthcare sector. Owing to the increasing spread of the virus there was an increased demand for influenza vaccines. This had a positive impact on the growth of the global Influenza Vaccines Market.

Key Takeaways:

The global Influenza Vaccines Market is estimated to witness robust growth, exhibiting CAGR of 4.2 % over the forecast period, due to rising product launches. For instance, Fluzone, a high-dose influenza vaccine was launched by Sanofi in March 2022, for protection against four strains.

North America is anticipated to witness significant growth in the global market for influenza vaccines during the forecast period, due to rising technological advancement in vaccine production facilities and increasing incidences of influenza infection in the U.S.

Key players active in the global Influenza Vaccines Market are EMERGEX VACCINES, GSK plc, OSIVAX, AstraZeneca, Viatris Inc., SINOVAC, Merck & Co., Inc., Pfizer Inc, EMERGENT, Vaxess Technologies Inc, and CSL Limited.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more